Ensuring Successful Clinical and Commercial Translation of NK Cell Immunotherapies
The 3rd annual Innate Killer Summit will provide a platform for leaders in the NK field to network, interact and learn at the only end-to-end meeting that fosters the transformation of leading science to commercial therapies. In addition to accessing cutting-edge novel innovations and the latest clinical data, leave the Innate Killer Summit fully equipped to progress your NK cell therapy pipeline with a forward-looking plan for global manufacturing.
Join the leading scientific and business experts from all the key stakeholders to identify future approaches to deliver commercially viable off-the-shelf therapies….view speaker line-up
“This meeting will be one of the first opportunities to bring together the leading Innate Killer Cell companies in a focused setting." - Fortress Biotech